BCCP Practice Questions - Board Certified Cardiology Pharmacist Exam

Access More Questions

According to the 2018 ACC/AHA cholesterol guideline and 2022 ECDP, what is the LDL-C threshold for considering PCSK9 inhibitor therapy in very high-risk ASCVD patients?

LDL-C >=40 mg/dL LDL-C >=55 mg/dL LDL-C >=70 mg/dL LDL-C >=100 mg/dL

Correct Answer:

LDL-C >=55 mg/dL

Access more questions from this quiz

Continue to BCCP Practice Questions - Board Certified Cardiology Pharmacist Exam for more practice questions and the full quiz experience.

Access More Questions